Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Animal Care Committees | 4 | 2014 | 12 | 1.450 |
Why?
|
| Animal Welfare | 4 | 2012 | 40 | 0.810 |
Why?
|
| Housing, Animal | 2 | 2012 | 41 | 0.680 |
Why?
|
| Leadership | 1 | 2018 | 267 | 0.500 |
Why?
|
| Hospitals | 1 | 2018 | 484 | 0.480 |
Why?
|
| Pets | 1 | 2014 | 16 | 0.470 |
Why?
|
| Ownership | 1 | 2014 | 40 | 0.450 |
Why?
|
| Anesthesia | 2 | 2008 | 307 | 0.410 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 705 | 0.390 |
Why?
|
| Animal Technicians | 2 | 2008 | 7 | 0.380 |
Why?
|
| Laboratory Animal Science | 2 | 2008 | 24 | 0.370 |
Why?
|
| Physicians | 1 | 2018 | 854 | 0.340 |
Why?
|
| Guideline Adherence | 1 | 2014 | 632 | 0.340 |
Why?
|
| Auditory Threshold | 1 | 2007 | 28 | 0.280 |
Why?
|
| Noise | 1 | 2007 | 33 | 0.280 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 563 | 0.260 |
Why?
|
| Clinical Competence | 2 | 2018 | 1323 | 0.260 |
Why?
|
| Rabbits | 1 | 2006 | 1028 | 0.250 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2005 | 207 | 0.240 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2005 | 236 | 0.210 |
Why?
|
| Intraoperative Complications | 1 | 2004 | 288 | 0.200 |
Why?
|
| Pain | 2 | 2008 | 1699 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 4 | 2010 | 7103 | 0.170 |
Why?
|
| Cornea | 1 | 2004 | 681 | 0.160 |
Why?
|
| Morale | 1 | 2018 | 5 | 0.160 |
Why?
|
| PubMed | 1 | 2018 | 32 | 0.150 |
Why?
|
| Animals | 13 | 2015 | 62051 | 0.120 |
Why?
|
| Rats | 1 | 2004 | 6525 | 0.120 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 2014 | 18 | 0.120 |
Why?
|
| Body Temperature | 1 | 2014 | 164 | 0.110 |
Why?
|
| Temperature | 1 | 2014 | 538 | 0.110 |
Why?
|
| Heterografts | 1 | 2015 | 739 | 0.110 |
Why?
|
| Spermatogenesis | 1 | 2014 | 268 | 0.100 |
Why?
|
| Fatal Outcome | 2 | 2005 | 824 | 0.100 |
Why?
|
| Testis | 1 | 2014 | 620 | 0.100 |
Why?
|
| Adenoviruses, Simian | 1 | 2010 | 5 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2011 | 9042 | 0.090 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2010 | 43 | 0.090 |
Why?
|
| Mice | 9 | 2015 | 35598 | 0.080 |
Why?
|
| Leucine | 1 | 2011 | 380 | 0.080 |
Why?
|
| Pulmonary Fibrosis | 1 | 2010 | 175 | 0.080 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 4499 | 0.080 |
Why?
|
| Isoflurane | 1 | 2008 | 69 | 0.080 |
Why?
|
| Anesthetics, Inhalation | 1 | 2008 | 65 | 0.070 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 591 | 0.070 |
Why?
|
| Environmental Pollution | 1 | 2007 | 18 | 0.070 |
Why?
|
| Hearing | 1 | 2007 | 64 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2005 | 7915 | 0.070 |
Why?
|
| Lymphoma | 1 | 2014 | 1520 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 25 | 1 | 2005 | 2 | 0.060 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2005 | 146 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2010 | 1857 | 0.060 |
Why?
|
| Animal Experimentation | 1 | 2004 | 6 | 0.060 |
Why?
|
| Rats, Long-Evans | 1 | 2004 | 111 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2011 | 1564 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2010 | 1656 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2007 | 493 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 2073 | 0.050 |
Why?
|
| Liver Cirrhosis | 1 | 2010 | 1046 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 3657 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2010 | 4224 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 5404 | 0.050 |
Why?
|
| Humans | 7 | 2018 | 270880 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2006 | 1468 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2015 | 4329 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2011 | 12103 | 0.030 |
Why?
|
| Receptor Activity-Modifying Protein 3 | 1 | 2014 | 19 | 0.030 |
Why?
|
| Receptors, Calcitonin | 1 | 2014 | 28 | 0.030 |
Why?
|
| Tumor Protein p73 | 1 | 2014 | 114 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 7665 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2015 | 16212 | 0.030 |
Why?
|
| Thymus Gland | 1 | 2014 | 311 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 655 | 0.030 |
Why?
|
| Receptor, ErbB-2 | 2 | 2015 | 2651 | 0.030 |
Why?
|
| Cell Line, Tumor | 3 | 2014 | 14841 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 7386 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2014 | 4117 | 0.020 |
Why?
|
| Ice Cover | 1 | 2010 | 4 | 0.020 |
Why?
|
| Factor X | 1 | 2010 | 10 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 2455 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2014 | 1126 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 2010 | 79 | 0.020 |
Why?
|
| Kupffer Cells | 1 | 2010 | 41 | 0.020 |
Why?
|
| Serotyping | 1 | 2010 | 192 | 0.020 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2010 | 41 | 0.020 |
Why?
|
| Lac Operon | 1 | 2010 | 133 | 0.020 |
Why?
|
| Basement Membrane | 1 | 2010 | 143 | 0.020 |
Why?
|
| Adenoviruses, Human | 1 | 2010 | 191 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2014 | 1137 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2010 | 187 | 0.020 |
Why?
|
| Lymphokines | 1 | 2010 | 313 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2010 | 232 | 0.020 |
Why?
|
| Species Specificity | 1 | 2010 | 794 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2010 | 314 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2014 | 1624 | 0.020 |
Why?
|
| Female | 5 | 2015 | 149029 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 2170 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2010 | 756 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 1496 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2015 | 4001 | 0.020 |
Why?
|
| Collagen | 1 | 2010 | 726 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2010 | 804 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 1903 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2010 | 518 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2005 | 10707 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 2453 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 3588 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 1109 | 0.010 |
Why?
|
| Skin | 1 | 2010 | 1274 | 0.010 |
Why?
|
| Male | 3 | 2014 | 128463 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2010 | 1301 | 0.010 |
Why?
|
| Base Sequence | 1 | 2010 | 5437 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 10260 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 3440 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 3215 | 0.010 |
Why?
|
| Genetic Therapy | 1 | 2010 | 1714 | 0.010 |
Why?
|
| Gene Expression | 1 | 2010 | 3642 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2015 | 5231 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 5002 | 0.010 |
Why?
|
| Kidney | 1 | 2010 | 2121 | 0.010 |
Why?
|
| Cytokines | 1 | 2010 | 2826 | 0.010 |
Why?
|
| Liver | 1 | 2010 | 3088 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 7237 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 10395 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 31037 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 73417 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 82036 | 0.000 |
Why?
|
| Middle Aged | 1 | 2015 | 90382 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 12027 | 0.000 |
Why?
|